Novel Combination Therapies for the Treatment of Bladder Cancer

Bladder cancer is the ninth most frequently diagnosed cancer world-wide and ranks 13th in cancer-related deaths. Two tremendous breakthroughs in bladder cancer therapy over the last decades are the approval of immune checkpoint inhibitors(ICIs)and the fibroblast growth factor receptor tyrosine kinas...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Mei, Xiao, Di, Bu, Yizhi, Long, Jiahui, Yang, Xue, Lv, Shuhe, Yang, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873600/
https://www.ncbi.nlm.nih.gov/pubmed/33585182
http://dx.doi.org/10.3389/fonc.2020.539527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873600/
https://www.ncbi.nlm.nih.gov/pubmed/33585182
http://dx.doi.org/10.3389/fonc.2020.539527

Ejemplares similares